Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
PEKK is a high-performance polymer family used in aerospace and other demanding markets
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Subscribe To Our Newsletter & Stay Updated